Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome by Lanfear David E, Jones Philip G, Marsh Sharon, Cresci Sharon, McLeod Howard L, Spertus John A in JAMA : the journal of the American Medical Association (2005).

[PMID: 16189366] PubMed


Previous data support an association between polymorphisms of the beta1- and beta2-adrenergic receptors (ADRB1 and ADRB2) and surrogate end points of response to beta-adrenergic blocker therapy. However, no associations between these polymorphisms and mortality have been demonstrated.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.